UnknownPhase 2NCT00971685
The Treatment of Lenalidomide in Patients With POEMS Syndrome
Studying POEMS syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Istituto Clinico Humanitas
- Principal Investigator
- Armando Santoro, MDIstituto Clinico Humanitas
- Intervention
- Lenalidomide and dexamethasone(drug)
- Enrollment
- 16 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2009 – 2011
Study locations (1)
- Istituto Clinco Humanitas, Rozzano, Milano, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00971685 on ClinicalTrials.govOther trials for POEMS syndrome
Additional recruiting or active studies for the same condition.